Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,006,812 papers from all fields of science
Search
Sign In
Create Free Account
Familial ependymoma
Known as:
Pediatric Ependymoma
, brain tumor, childhood ependymoma
, ependymoma, childhood
Expand
An ependymoma that arises from the central nervous system and occurs during childhood.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Anaplasia
Calcinosis
Central Nervous System
Ependymal cell
Expand
Broader (1)
Ependymoma
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar
,
Jonathan Clark
,
+37 authors
S. Venneti
Acta Neuropathologica
2017
Corpus ID: 3490141
Posterior fossa ependymomas (EPN_PF) in children comprise two morphologically identical, but biologically distinct tumor entities…
Expand
Review
2017
Review
2017
Current therapy and the evolving molecular landscape of paediatric ependymoma.
S. Khatua
,
V. Ramaswamy
,
E. Bouffet
European Journal of Cancer
2017
Corpus ID: 28869201
Highly Cited
2016
Highly Cited
2016
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
C. Peeler
,
D. Mirkovic
,
+5 authors
D. Grosshans
Radiotherapy and Oncology
2016
Corpus ID: 4005447
Review
2011
Review
2011
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
D. Ellison
,
M. Koçak
,
+8 authors
R. Grundy
Journal of Negative Results in Biomedicine
2011
Corpus ID: 6835213
BackgroundHistopathological grading of ependymoma has been controversial with respect to its reproducibility and clinical…
Expand
Review
2009
Review
2009
Pediatric Ependymoma: Biological Perspectives
J. Kilday
,
R. Rahman
,
+4 authors
R. Grundy
Molecular Cancer Research
2009
Corpus ID: 2409031
Pediatric ependymomas are enigmatic tumors that continue to present a clinical management challenge despite advances in…
Expand
Highly Cited
2008
Highly Cited
2008
Predicting change in academic abilities after conformal radiation therapy for localized ependymoma.
H. Conklin
,
Chenghong Li
,
X. Xiong
,
R. Ogg
,
T. Merchant
Journal of Clinical Oncology
2008
Corpus ID: 780304
PURPOSE Conformal radiation therapy (CRT) aims to limit the highest radiation dose to the tissue volume at risk while sparing…
Expand
Review
2004
Review
2004
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
M. Massimino
,
L. Gandola
,
+25 authors
E. Madon
International Journal of Radiation Oncology…
2004
Corpus ID: 12954508
Highly Cited
2002
Highly Cited
2002
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
R. Gilbertson
,
L. Bentley
,
+8 authors
D. Ellison
Clinical Cancer Research
2002
Corpus ID: 2007601
PURPOSE This study was designed to investigate the biological and therapeutic significance of ERBB1, ERBB2, ERBB3, and ERBB4 in…
Expand
Highly Cited
1990
Highly Cited
1990
Prognostic factors in childhood ependymomas.
L. Sutton
,
J. Goldwein
,
+4 authors
R. Packer
Pediatric Neurosurgery
1990
Corpus ID: 3315328
Between 1975 and 1989, 45 children with newly diagnosed intracranial ependymomas were treated at the authors' institution…
Expand
Highly Cited
1975
Highly Cited
1975
The biology of childhood ependymomas.
R. Shuman
,
E. Alvord
,
R. Leech
Archives of Neurology
1975
Corpus ID: 34998103
The biology of 74 childhood ependymomas has been retrospectively investigated in total population samples from three hospitals in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required